首页> Chemical biology and drug design> Phenylbutazone, a New Long-Acting Agent that can Improve the Peptide Pharmacokinetic Based on Serum Albumin as a Drug Carrier

Phenylbutazone, a New Long-Acting Agent that can Improve the Peptide Pharmacokinetic Based on Serum Albumin as a Drug Carrier

导出原文传递

翻译打印收藏纠错

第一作者： Zhou, Jie

作者： Zhou, Jie ^[1] ; Li, Xue ^[1] ; Zhu, Xiaoyun ^[1] ; Sun, Jian ^[1] ; Qiu, Qianqian ^[1] ; Huang, Wenlong ^[1] ; Qian, Hai ^[1]

作者单位： China Pharmaceut Univ, Ctr Drug Discovery, State Key Lab Nat Med, Nanjing 210009, Peoples R China ^[1]

关键词 anorexia HSA obesity PYY24-36 conjugate weight loss

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Chemical biology and drug design

2016年87卷6期

936-945页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Chemical biology and drug design

2016年87卷6期

936-945页

检索历史清除

Phenylbutazone, a New Long-Acting Agent that can Improve the Peptide Pharmacokinetic Based on Serum Albumin as a Drug Carrier

Chemical biology and drug design

相似文献

同项目论文

Chemical biology and drug design

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phenylbutazone, a New Long-Acting Agent that can Improve the Peptide Pharmacokinetic Based on Serum Albumin as a Drug Carrier

Chemical biology and drug design

相似文献

同项目论文

Chemical biology and drug design

相关期刊

检索历史清除